{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"萌喵读文献-肿瘤学","title":"今日肿瘤学最高分文献 - 2025-07-02","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/d07bba5c\"></iframe>","width":"100%","height":180,"duration":106,"description":"欢迎收听科研喵播客，使用AI读文献，祝你效率百倍，访问labcat.com.cn下载。今天的焦点是癌症治疗领域的一项革命性进展。研究发现，HRProfiler，一个基于机器学习的新工具，能够通过全外显子测序数据，准确检测癌症中的同源重组缺陷（HRD）。HRD是乳腺癌和卵巢癌等癌症的重要生物标志物，能预测患者对铂类化疗和PARP抑制剂的反应。HRProfiler不仅提高了检测的准确性，还降低了成本，使更多患者能够接受基因组引导的精准治疗。这项研究发表在《Cancer Research》杂志上，标志着我们向更个性化的癌症治疗迈出了一大步。","thumbnail_url":"https://img.transistorcdn.com/3WX36CzvFOrNjlF7WfWjzS4HdcMIMmzMs2bmPS-ejLU/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NDNm/MjQ1N2E5NjhjMzVj/NjM0ZTA3YzY2NDE2/ZmIyMi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}